We're in beta — help us improve the future of brain health!

Benefits of Testing

Early detection is the key to better care, and more time

Early detection of elevated pTau217 can lead to better care and better outcomes for dementia due to Alzheimer's disease. Learn how early testing can give you and your loved ones more time.

The difference early testing can make

Detecting Alzheimer's early allows for timely treatment and lifestyle adjustments, which can help slow disease progression and improve quality of life.

Take Action Years Earlier

Our biomarker blood test and our cognitive assessment provide predictive insights into your brain health. Together, the results give you a baseline assessment of your brain health and guidance of follow-up care.

Slow Disease Progression

When you catch Alzheimer's early, there are many validated medical options and lifestyle changes that can help slow the progression of the disease, which may reduce your risk of cognitive decline and dementia by up to 60%.

Stay Independent Longer

With more time on your side, you are able to create strategies, support networks and a personalized care plan that can help you better maintain your independence and quality of life.

Am I a good candidate for testing?

As you age, your risk for Alzheimer's increases. That's why early detection is crucial for adults 55 and older who have cognitive health risk factors. For those individuals, Neurogen may be a good fit to better understand their cognitive health.

People experiencing memory issues or cognitive decline

Examples include difficulty with problem-solving, confusion with time or place, or frequent memory lapses.

Those aged 55 and older

Age is the greatest risk factor for Alzheimer's, especially if accompanied by risk factors like heart disease, diabetes, or high blood pressure.

Individuals with a family history

An individual's genetics can increase their risk for developing Alzheimer's or other forms of dementia. For people over 40 with a family history of Alzheimer's, testing can be helpful for early detection.

Empowering action

We’ve built an ecosystem that allows people to detect Alzheimer’s years earlier than was previously possible. But it doesn’t stop there. We empower people to move forward, gaining knowledge and taking action to develop a personalized cognitive care plan.

Early Testing

The Neurogen At-Home-Test Kit gives you direct access to cutting-edge testing technology to detect pTau217, a blood biomarker for Alzheimer's disease pathology, right from home. In addition to an at-home blood biomarker test, participants complete an online assessment to give us a holistic look at your brain health.

After receiving your kit, a nurse or health professional will guide you through the sample collection process to ensure accuracy and comfort.

Dedicated Neurologist

If your test detects Alzheimer's, you will be assigned a dedicated board-certified neurologist, who will walk through your results with you. After your telehealth consultation, you can continue to work with this neurologist to develop a cognitive care plan that matches your needs.

Brain Action Plan

You'll receive a personalized Brain Action Plan that we've built for you based on your test results and the health information you provided. This Action Plan will help you identify the steps you can take to lower your dementia risk by as much as 40%.

“Understanding the cause of cognitive impairment at the earliest possible time is critical for identifying the most appropriate treatment pathways. The combination of Neurogen’s blood-based biomarker and ecosystem for explanation of results and care can make a big difference in patient’s treatment plans.”

- Dr. Michelle Mielke

Professor of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine